b'6 IMPACTLONGEVITY|HUMAN HEALTHAging is malleable. Longevity is a mechanism able to be manipulated. After winning a Thiel Fellowship at the age of 16in 2008, Laura Deming left MIT. In 2011 she raised $22 million and founded The Longevity Fund venturecapital firm. In 2018, she shared her unique story with the SciTech audience, along with her passion SciTech 2015-2018 to increase human health and lifespan bypreventing and reversing age-related disease.Photo by TechCrunch, Kimberly WhiteScienceandtechnologyaretransforminghowwediagnose,treat,andmanage diseases and other modern health challenges. At SciTech, participants can experience, first-hand,thepassionandknowledgeoflocalandinternationalchangemakers who are meeting these challenges. They inspire the imagination of students,scientists and our entire community.2015-201692415Young at Heart 91516Inflammation Nation & 92817Breaking the Cycle of Addiction 2017-2018Dr. Barbara A. Pisani, Cardiology ProfessorThe Rewired Brain with Next Generation NeurotherapeuticsWake Forest School of MedicineDr. Ski Chilton, Professor, Wake Forest School Aaron Lazarus, CEO, EncepHeal Therapeutics101515My Journey from Higher Educationof Medicine 101917How Students and Companies Use into the Biopharmaceutical Industry 101316Update on Carolina Liquid the Analytical and Molecular Training LabDr. Norma V. Quiones, Biogen Chemistries Corp. and New EmployeesJason Gagliano, Lab Coordinator & MalaysiaPatti Shugart, VP and COO, Carolina Liquid Christian, Lab Technician111915Healing, Fueling, and Feeding Chemistries Corporationthe World 111616Medical Device Development2818Using Biological Research to Doug Edgeton, President & CEO, Barry Slowey, President and Vihur Surti, Director Reduce or Reverse the Effects of Aging NC Biotechnology Center of R&D, Cook Medical Endoscopy Division and Increase Longevity12616A Passage to Biotech in India 121516Retirement and Antibodies Laura Deming, Director, Longevity Fund2016-2017Russ H. Read, Executive Director, National Alan Beard, Chair, Forsyth Tech Biotech Department 22218Adventures in Innovation from Center for the Biotechnology Workforce 11917Confessions of a Serial Laboratory Bench to the Stratosphere21816An Innovator in EntrepreneurDr. Michael Batalia, Co-Founder, WideEy3DAnimal and Human Health Kim Westmoreland, Founder & CEO, KeraNetics, LLC 31518The Physical and Chemical Roland Johnson, Founder and CEO of Piedmont 21617KPC-34 a Co-Drug Combining a Properties of SmokePharmaceuticals & Animal Health DNA Damaging Agent with a TargetedNorman Fraley, Executive Director, Frolich Institute31716A Visit to Chernobyl - Therapy 45183D Bioprinting = Materials + Past, Present & Future Dr. Gregory Kucera, Professor, Hematology and Manufacturing + MedicineDr. Travis Russell, Forsyth Tech Oncology, Wake Forest School of Medicine Dr. Rohan A. Shirwaiker,Associate Professor31617Exploring the World for Novel& Faculty Scholar, Fitts Department of IndustrialMedicinal Compounds and Education & Systems Engineering, NCSUAmy Greeson R.Ph., CEO, Natural DiscoveriesNCSUs new ultrasound-assisted fabrication process allows bioengineers to use a patients own living cells to create complex tissues like this meniscus, without sacrificing the strength and flexibility of natural tissues.3D BIOPRINTING - TISSUE ENGINEERINGWith 3D bioprinting, we can create biologically-active implants using livingcells. Using ultrasound in conjunctionwith 3D bioprinting allows us to moreclosely mimic the organization andstrength of natural tissues. At NC State, Dr. Rohan Shirwaiker works withan interdisciplinary research team to engineer anew generation of tissue implants to overcomelimitations of traditional metal and polymer devices.'